Olanzapine

This classification denotes an antipsychotic agent with the molecular formula C17H20N4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N7U69T4SZR, chemically known as 10h-thieno(2,3-b)(1,5)benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)- but generally known as olanzapine, which bears US NIH Compound Identifier 4585. European Medicines Agency schedules Olanzapine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09426MIG. The term OLANZAPINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, No3, 1993, List 33). World Health Organization schedules olanzapine in its Anatomical Therapeutic Chemical (ATC) Classification. OLANZAPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule olanzapine under HS 29349990 and SITC 51579. As of Q4 2014, OLANZAPINE remains the US FDA Preferred Term for this commodity. Olanzapine bears US NLM identifiers UMLS ID C0171023 and NCI Concept Code C47639. SMILES: S1C2=NC3C(NC(=C2CC1C)N1CCN(CC1)C)CCCC3.